Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
159M
-
Shares change
-
+23.2M
-
Total reported value, excl. options
-
$2.29B
-
Value change
-
+$378M
-
Put/Call ratio
-
0.43
-
Number of buys
-
122
-
Number of sells
-
-70
-
Price
-
$14.36
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q3 2025
230 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value as of Q3 2025.
Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 159M shares
of 160M outstanding shares and own 99.27% of the company stock.
Largest 10 shareholders include FMR LLC (22.4M shares), BlackRock, Inc. (10.4M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (9.05M shares), Fairmount Funds Management LLC (9M shares), Kynam Capital Management, LP (7.89M shares), VANGUARD GROUP INC (7.76M shares), Commodore Capital LP (7.25M shares), TCG Crossover Management, LLC (6.8M shares), STATE STREET CORP (4.78M shares), and VR ADVISER, LLC (4M shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.